+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Memorandum of understanding between the Food and Drug Administration and the U.S. Army Medical Research and Material Command. Food and Drug Administration, HHS. Notice



Memorandum of understanding between the Food and Drug Administration and the U.S. Army Medical Research and Material Command. Food and Drug Administration, HHS. Notice



Federal Register 64(95): 26988-26991



The Food and Drug Administration (FDA) is providing notice of a memorandum of understanding (MOU) between FDA and the U.S. Army Medical Research and Material Command. The purpose of the MOU is to define responsibilities during the research, development, and pre-marketing acquisition of medical material for military applications.

Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 046662148

Download citation: RISBibTeXText

PMID: 10558528


Related references

Food and Drug Administration Modernization Act of 1997; list of documents issued by the Food and Drug Administration that apply to medical devices regulated by the Center for Biologics Evaluation and Research. Food and Drug Administration, HHS. Notice. Federal Register 64(79): 20312-3, 1999

Memorandum of understanding between the Food and Drug Administration and the Defense Alliance for Advanced Medical Terminology--FDA. Notice. Federal Register 63(129): 36700-6, 1998

Memorandum of understanding between the Food and Drug Administration and the Indian Health Service--FDA. Notice. Federal Register 63(135): 38182-8, 1998

Memorandum of understanding between the Food and Drug Administration and the National Institutes of Health's National Institute of Dental Research--FDA. Notice. Federal Register 63(105): 30002-5, 1998

Agreed minutes; meeting between the Food and Drug Administration and the Health Authorities of Switzerland. Food and Drug Administration, HHS. Notice. Federal Register 64(107): 30038-30040, 1999

Memorandum of agreement between the Production and Marketing Administration and the Food and Drug Administration concerning the inspection and standardization activities related to food products. 1953

International Conference on Harmonisation; Electronic Transmission of Postmarket Individual Case Safety Reports for Drugs and Biologics, Excluding Vaccines; Availability of Food and Drug Administration Regional Implementation Specifications for ICH E2B(R3) Reporting to the Food and Drug Administration Adverse Event Reporting System. Notice of Availability. Federal Register 81(121): 40890-1, 2016

Medical device warning letter pilot. Food and Drug Administration, HHS. Notice. Federal Register 64(44): 11018-11023, 1999

Off-label antidepressant prescription in pediatric outpatients based on China Food and Drug Administration and Food and Drug Administration regulations: a Chinese retrospective study. International Clinical Psychopharmacology 33(3): 172-179, 2018

Going 90 in a 55 M.P.H. speed zone: reprocessing of used single-use medical devices and the Food and Drug Administration's non-enforcement of the Food, Drug, and Cosmetic Act. Food and Drug Law Journal 56(1): 57-76, 2002

Can the U.S. Food and Drug Administration act against global frauds? The extraterritorial effect of Food and Drug Administration sanctions after Small v. United States. Food and Drug Law Journal 60(3): 347-360, 2005

Revocation of Office of Generic Drug's interim policy statement on inactive ingredients. Food and Drug Administration, HHS. Notice. Federal Register 64(83): 23340-1, 1999

11th annual conference of the usa food and drug administration and drug law institute on food and drug contaminants and related problems arlington virginia usa november 27 1967 symposium microorganism drug quality. Medical Annals Of The District Of Columbia: 131, 1968

Parenteral drug products containing aluminum as an ingredient or a contaminant: response to food and drug administration notice of intent and request for information. Journal of Parenteral and Enteral Nutrition 15(2): 194-198, 1991

Agency information collection activities; announcement of OMB approval; medical devices: third-party review program under the U.S./EC MRA. Food and Drug Administration, HHS. Notice. Federal Register 64(44): 11018-11018, 1999